B. Liu


Postal address:
A Deusinglaan
Phone: +31 50 363 7866
  1. Inhibition of Histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing

    Liu, B., Chen, S., La Rose, A., Chen, D., Cao, F., Kiemel, D., Aïssi, M., Dekker, F. & Haisma, H., 13-Jun-2019, (Accepted/In press) In : bioRxiv.

    Research output: Contribution to journalArticleAcademic

  2. Histone Deacetylase Inhibitors Sensitize TRAIL-Induced Apoptosis in Colon Cancer Cells

    Zhang, B., Liu, B., Chen, D., Setroikromo, R., Haisma, H. J. & Quax, W. J., 10-May-2019, In : Cancers. 11, 5, 16 p., 645.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. CRISPR/Cas9: A powerful tool for identification of new targets for cancer treatment

    Liu, B., Saber, A. & Haisma, H. J., 10-Mar-2019, In : Drug Discovery Today.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. CRISPR/Cas9 for overcoming drug resistance in solid tumors

    Saber, A., Liu, B., Ebrahimi, P. & Haisma, H., 21-Jan-2019, In : Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (5) »

View graph of relations

ID: 24020248